Behavioral naltrexone therapy: An integrated treatment for opiate dependence

Jami L. Rothenberg, Maria A. Sullivan, Sarah H. Church, Angela Seracini, Eric Collins, Herbert D. Kleber, Edward V. Nunes

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Treatment of opiate dependence with naltrexone has been limited by poor compliance. Behavioral Naltrexone Therapy (BNT) was developed to promote adherence to naltrexone and lifestyle changes supportive of abstinence, by incorporating components from empirically validated treatments, including Network Therapy with a significant other to monitor medication compliance, the Community Reinforcement Approach, and voucher incentives. An overview is presented of the BNT treatment manual. In an uncontrolled Stage I trial (N = 47), 19% completed the 6-month course of treatment. Retention was especially poor in the subsample of patients who were using methadone at baseline (N = 18; 39% completed 1 month, none completed 6 months), and more encouraging among heroin-dependent patients (N = 29; 65% completed 1 month, 31% completed 6 months). Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted.

Original languageEnglish (US)
Pages (from-to)351-360
Number of pages10
JournalJournal of Substance Abuse Treatment
Volume23
Issue number4
DOIs
StatePublished - Dec 2002

Fingerprint

Opioid-Related Disorders
Naltrexone
Therapeutics
Musculoskeletal Manipulations
Medication Adherence
Methadone
Heroin
Life Style
Motivation

Keywords

  • Behavior therapy
  • Heroin
  • Naltrexone
  • Treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Rothenberg, J. L., Sullivan, M. A., Church, S. H., Seracini, A., Collins, E., Kleber, H. D., & Nunes, E. V. (2002). Behavioral naltrexone therapy: An integrated treatment for opiate dependence. Journal of Substance Abuse Treatment, 23(4), 351-360. https://doi.org/10.1016/S0740-5472(02)00301-X

Behavioral naltrexone therapy : An integrated treatment for opiate dependence. / Rothenberg, Jami L.; Sullivan, Maria A.; Church, Sarah H.; Seracini, Angela; Collins, Eric; Kleber, Herbert D.; Nunes, Edward V.

In: Journal of Substance Abuse Treatment, Vol. 23, No. 4, 12.2002, p. 351-360.

Research output: Contribution to journalArticle

Rothenberg, JL, Sullivan, MA, Church, SH, Seracini, A, Collins, E, Kleber, HD & Nunes, EV 2002, 'Behavioral naltrexone therapy: An integrated treatment for opiate dependence', Journal of Substance Abuse Treatment, vol. 23, no. 4, pp. 351-360. https://doi.org/10.1016/S0740-5472(02)00301-X
Rothenberg, Jami L. ; Sullivan, Maria A. ; Church, Sarah H. ; Seracini, Angela ; Collins, Eric ; Kleber, Herbert D. ; Nunes, Edward V. / Behavioral naltrexone therapy : An integrated treatment for opiate dependence. In: Journal of Substance Abuse Treatment. 2002 ; Vol. 23, No. 4. pp. 351-360.
@article{b9c255b36ed44f7c814383cccb8b2ceb,
title = "Behavioral naltrexone therapy: An integrated treatment for opiate dependence",
abstract = "Treatment of opiate dependence with naltrexone has been limited by poor compliance. Behavioral Naltrexone Therapy (BNT) was developed to promote adherence to naltrexone and lifestyle changes supportive of abstinence, by incorporating components from empirically validated treatments, including Network Therapy with a significant other to monitor medication compliance, the Community Reinforcement Approach, and voucher incentives. An overview is presented of the BNT treatment manual. In an uncontrolled Stage I trial (N = 47), 19{\%} completed the 6-month course of treatment. Retention was especially poor in the subsample of patients who were using methadone at baseline (N = 18; 39{\%} completed 1 month, none completed 6 months), and more encouraging among heroin-dependent patients (N = 29; 65{\%} completed 1 month, 31{\%} completed 6 months). Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted.",
keywords = "Behavior therapy, Heroin, Naltrexone, Treatment",
author = "Rothenberg, {Jami L.} and Sullivan, {Maria A.} and Church, {Sarah H.} and Angela Seracini and Eric Collins and Kleber, {Herbert D.} and Nunes, {Edward V.}",
year = "2002",
month = "12",
doi = "10.1016/S0740-5472(02)00301-X",
language = "English (US)",
volume = "23",
pages = "351--360",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Behavioral naltrexone therapy

T2 - An integrated treatment for opiate dependence

AU - Rothenberg, Jami L.

AU - Sullivan, Maria A.

AU - Church, Sarah H.

AU - Seracini, Angela

AU - Collins, Eric

AU - Kleber, Herbert D.

AU - Nunes, Edward V.

PY - 2002/12

Y1 - 2002/12

N2 - Treatment of opiate dependence with naltrexone has been limited by poor compliance. Behavioral Naltrexone Therapy (BNT) was developed to promote adherence to naltrexone and lifestyle changes supportive of abstinence, by incorporating components from empirically validated treatments, including Network Therapy with a significant other to monitor medication compliance, the Community Reinforcement Approach, and voucher incentives. An overview is presented of the BNT treatment manual. In an uncontrolled Stage I trial (N = 47), 19% completed the 6-month course of treatment. Retention was especially poor in the subsample of patients who were using methadone at baseline (N = 18; 39% completed 1 month, none completed 6 months), and more encouraging among heroin-dependent patients (N = 29; 65% completed 1 month, 31% completed 6 months). Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted.

AB - Treatment of opiate dependence with naltrexone has been limited by poor compliance. Behavioral Naltrexone Therapy (BNT) was developed to promote adherence to naltrexone and lifestyle changes supportive of abstinence, by incorporating components from empirically validated treatments, including Network Therapy with a significant other to monitor medication compliance, the Community Reinforcement Approach, and voucher incentives. An overview is presented of the BNT treatment manual. In an uncontrolled Stage I trial (N = 47), 19% completed the 6-month course of treatment. Retention was especially poor in the subsample of patients who were using methadone at baseline (N = 18; 39% completed 1 month, none completed 6 months), and more encouraging among heroin-dependent patients (N = 29; 65% completed 1 month, 31% completed 6 months). Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted.

KW - Behavior therapy

KW - Heroin

KW - Naltrexone

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0036911055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036911055&partnerID=8YFLogxK

U2 - 10.1016/S0740-5472(02)00301-X

DO - 10.1016/S0740-5472(02)00301-X

M3 - Article

C2 - 12495797

AN - SCOPUS:0036911055

VL - 23

SP - 351

EP - 360

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 4

ER -